Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1

The long non-coding RNA MALAT1 interacted with miR-218 modulates choriocarcinoma growth by targeting Fbxw8

(2018) Dazun Shi et al.   BIOMEDICINE & PHARMACOTHERAPY

Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR

(2017) Te Liu et al.   GENE

The Long Non-Coding RNA TP73-AS1 Interacted With miR-142 to Modulate Brain Glioma Growth Through HMGB1/RAGE Pathway

(2017) Rong Zhang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2

(2017) Peilong Li et al.   MOLECULAR CANCER THERAPEUTICS

MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer

(2017) Wenjing Zhu et al.   MOLECULAR CARCINOGENESIS

Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer

(2016) Yalong Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

miR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression

(2016) FUJUN LI et al.   ONCOLOGY REPORTS

LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway

(2016) Dong Xue et al.   TUMOR BIOLOGY

PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells

(2016) Ana Emília Goulart Lemos et al.   TUMOR BIOLOGY

Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer

(2016) Bing Guan et al.   Oncotarget

Long non-coding RNAs harboring miRNA seed regions are enriched in prostate cancer exosomes

(2016) Alireza Ahadi et al.   Scientific Reports

microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression

(2015) Guangye Han et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer

(2015) J. K. Birnbaum et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNAPCA3

(2015) Ahmad Salameh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer

(2015) Bertrand Neveu et al.   Oncotarget

Fluctuation in prostate cancer gene 3 (PCA3) score in men undergoing first or repeat prostate biopsies

(2014) Stefano De Luca et al.   BJU INTERNATIONAL

MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer

(2013) C. Zhang et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Metabolomic and transcriptomic profiling of human K- ras oncogene transgenic rats with pancreatic ductal adenocarcinomas

(2013) Setsuko Yabushita et al.   CARCINOGENESIS

Identification of Differentially Expressed Proteins in Curcumin-Treated Prostate Cancer Cell Lines

(2012) Marie-Hélène Teiten et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience

(2012) Christian G. Ramos et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

HMGB1 release and redox regulates autophagy and apoptosis in cancer cells

(2010) D Tang et al.   ONCOGENE

Other biomarkers for detecting prostate cancer

(2009) Lucas Nogueira et al.   BJU INTERNATIONAL

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

(2008) Alexander Haese et al.   EUROPEAN UROLOGY